Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma

Hyun Gyu Lee, Hyemi Kim, Taekwon Son, Youngtae Jeong, Seungup Kim, Seung Myung Dong, Young Nyun Park, Jong Doo Lee, Jae Myun Lee, Jeon Han Park

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Hexokinase 2 (HK2) is a rate-determining enzyme in aerobic glycolysis, a process upregulated in tumor cells. HK2 expression is controlled by various transcription factors and epigenetic alterations and is heterogeneous in hepatocellular carcinomas (HCCs), though the cause of this heterogeneity is not known. DNA methylation in the HK2 promoter CpG island (HK2-CGI) and its surrounding regions (shore and shelf) has not previously been evaluated, but may provide clues about the regulation of HK2 expression. Here, we compared HK2 promoter methylation in HCCs and adjacent non-cancerous liver tissues using a HumanMethylation450 BeadChip array. We found that, while the HK2-CGI N-shore was hypomethylated, thereby enhancing HK2 expression, the HK2-CGI was itself hypermethylated in some HCCs. This hypermethylation suppressed HK2 expression by inhibiting interactions between HIF-1α and a hypoxia response element (HRE) located at -234/-230. HCCs that were HK2negative and had distinct promoter CGI methylation were denoted as having a HK2-CGI methylation phenotype (HK2-CIMP), which was associated with poor clinical outcome. These findings indicate that HK2-CGI N-shore hypomethylation and HK2-CGI hypermethylation affect HK2 expression by influencing the interaction between HIF 1α and HRE. HK2-CGI hypermethylation induces HK2-CIMP and could represent a prognostic biomarker for HCC.

Original languageEnglish
Pages (from-to)41798-41810
Number of pages13
JournalOncotarget
Volume7
Issue number27
DOIs
Publication statusPublished - 2016 Jul 5

Fingerprint

Hexokinase
Methylation
Hepatocellular Carcinoma
Response Elements
CpG Islands
Glycolysis
DNA Methylation
Epigenomics

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Lee, Hyun Gyu ; Kim, Hyemi ; Son, Taekwon ; Jeong, Youngtae ; Kim, Seungup ; Dong, Seung Myung ; Park, Young Nyun ; Lee, Jong Doo ; Lee, Jae Myun ; Park, Jeon Han. / Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma. In: Oncotarget. 2016 ; Vol. 7, No. 27. pp. 41798-41810.
@article{d0ee5448d31d48c8b8c68527115562cf,
title = "Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma",
abstract = "Hexokinase 2 (HK2) is a rate-determining enzyme in aerobic glycolysis, a process upregulated in tumor cells. HK2 expression is controlled by various transcription factors and epigenetic alterations and is heterogeneous in hepatocellular carcinomas (HCCs), though the cause of this heterogeneity is not known. DNA methylation in the HK2 promoter CpG island (HK2-CGI) and its surrounding regions (shore and shelf) has not previously been evaluated, but may provide clues about the regulation of HK2 expression. Here, we compared HK2 promoter methylation in HCCs and adjacent non-cancerous liver tissues using a HumanMethylation450 BeadChip array. We found that, while the HK2-CGI N-shore was hypomethylated, thereby enhancing HK2 expression, the HK2-CGI was itself hypermethylated in some HCCs. This hypermethylation suppressed HK2 expression by inhibiting interactions between HIF-1α and a hypoxia response element (HRE) located at -234/-230. HCCs that were HK2negative and had distinct promoter CGI methylation were denoted as having a HK2-CGI methylation phenotype (HK2-CIMP), which was associated with poor clinical outcome. These findings indicate that HK2-CGI N-shore hypomethylation and HK2-CGI hypermethylation affect HK2 expression by influencing the interaction between HIF 1α and HRE. HK2-CGI hypermethylation induces HK2-CIMP and could represent a prognostic biomarker for HCC.",
author = "Lee, {Hyun Gyu} and Hyemi Kim and Taekwon Son and Youngtae Jeong and Seungup Kim and Dong, {Seung Myung} and Park, {Young Nyun} and Lee, {Jong Doo} and Lee, {Jae Myun} and Park, {Jeon Han}",
year = "2016",
month = "7",
day = "5",
doi = "10.18632/oncotarget.9723",
language = "English",
volume = "7",
pages = "41798--41810",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "27",

}

Lee, HG, Kim, H, Son, T, Jeong, Y, Kim, S, Dong, SM, Park, YN, Lee, JD, Lee, JM & Park, JH 2016, 'Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma', Oncotarget, vol. 7, no. 27, pp. 41798-41810. https://doi.org/10.18632/oncotarget.9723

Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma. / Lee, Hyun Gyu; Kim, Hyemi; Son, Taekwon; Jeong, Youngtae; Kim, Seungup; Dong, Seung Myung; Park, Young Nyun; Lee, Jong Doo; Lee, Jae Myun; Park, Jeon Han.

In: Oncotarget, Vol. 7, No. 27, 05.07.2016, p. 41798-41810.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma

AU - Lee, Hyun Gyu

AU - Kim, Hyemi

AU - Son, Taekwon

AU - Jeong, Youngtae

AU - Kim, Seungup

AU - Dong, Seung Myung

AU - Park, Young Nyun

AU - Lee, Jong Doo

AU - Lee, Jae Myun

AU - Park, Jeon Han

PY - 2016/7/5

Y1 - 2016/7/5

N2 - Hexokinase 2 (HK2) is a rate-determining enzyme in aerobic glycolysis, a process upregulated in tumor cells. HK2 expression is controlled by various transcription factors and epigenetic alterations and is heterogeneous in hepatocellular carcinomas (HCCs), though the cause of this heterogeneity is not known. DNA methylation in the HK2 promoter CpG island (HK2-CGI) and its surrounding regions (shore and shelf) has not previously been evaluated, but may provide clues about the regulation of HK2 expression. Here, we compared HK2 promoter methylation in HCCs and adjacent non-cancerous liver tissues using a HumanMethylation450 BeadChip array. We found that, while the HK2-CGI N-shore was hypomethylated, thereby enhancing HK2 expression, the HK2-CGI was itself hypermethylated in some HCCs. This hypermethylation suppressed HK2 expression by inhibiting interactions between HIF-1α and a hypoxia response element (HRE) located at -234/-230. HCCs that were HK2negative and had distinct promoter CGI methylation were denoted as having a HK2-CGI methylation phenotype (HK2-CIMP), which was associated with poor clinical outcome. These findings indicate that HK2-CGI N-shore hypomethylation and HK2-CGI hypermethylation affect HK2 expression by influencing the interaction between HIF 1α and HRE. HK2-CGI hypermethylation induces HK2-CIMP and could represent a prognostic biomarker for HCC.

AB - Hexokinase 2 (HK2) is a rate-determining enzyme in aerobic glycolysis, a process upregulated in tumor cells. HK2 expression is controlled by various transcription factors and epigenetic alterations and is heterogeneous in hepatocellular carcinomas (HCCs), though the cause of this heterogeneity is not known. DNA methylation in the HK2 promoter CpG island (HK2-CGI) and its surrounding regions (shore and shelf) has not previously been evaluated, but may provide clues about the regulation of HK2 expression. Here, we compared HK2 promoter methylation in HCCs and adjacent non-cancerous liver tissues using a HumanMethylation450 BeadChip array. We found that, while the HK2-CGI N-shore was hypomethylated, thereby enhancing HK2 expression, the HK2-CGI was itself hypermethylated in some HCCs. This hypermethylation suppressed HK2 expression by inhibiting interactions between HIF-1α and a hypoxia response element (HRE) located at -234/-230. HCCs that were HK2negative and had distinct promoter CGI methylation were denoted as having a HK2-CGI methylation phenotype (HK2-CIMP), which was associated with poor clinical outcome. These findings indicate that HK2-CGI N-shore hypomethylation and HK2-CGI hypermethylation affect HK2 expression by influencing the interaction between HIF 1α and HRE. HK2-CGI hypermethylation induces HK2-CIMP and could represent a prognostic biomarker for HCC.

UR - http://www.scopus.com/inward/record.url?scp=85017187415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017187415&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.9723

DO - 10.18632/oncotarget.9723

M3 - Article

VL - 7

SP - 41798

EP - 41810

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 27

ER -